NCT01067859View on ClinicalTrials.gov

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

November 30, 2010

Conditions
Acute Heart Failure
Interventions
DRUG

Cinaciguat (BAY58-2667)

Infusion of 25 µg/h during 48 hours

DRUG

Cinaciguat (BAY58-2667)

Infusion of 10 µg/h during 48 hours

DRUG

Placebo

Infusion of placebo during 48 hours

Trial Locations (30)

1070

Bruxelles - Brussel

1078

Buenos Aires

1102

Quezon City

3000

Leuven

6020

Innsbruck

8020

Graz

9300

Aalst

12559

Berlin

19141

Philadelphia

31403

Toulouse

32209

Jacksonville

32545

Bad Oeynhausen

35294

Birmingham

40225

Düsseldorf

43210

Columbus

44280

Guadalajara

44670

Guadalajara

57000

Mexico City

61231

Bad Nauheim

75475

Paris

79189

Bad Krozingen

94010

Créteil

02114

Boston

45267-0542

Cincinnati

Unknown

Quilmes

México D.F.

C1039AAO

Buenos Aires

C1181ACH

Buenos Aires

C1428DCO

Buenos Aires

DUBLIN 9

Dublin

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY